Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentSelling, General & Administrative
Others
Ratios

enVVeno Medical (NVNO) Operating Expenses (2017 - 2020)

enVVeno Medical has reported Operating Expenses over the past 4 years, most recently at $4.2 million for Q4 2020.

  • For Q4 2020, Operating Expenses rose 143.16% year-over-year to $4.2 million; the TTM value through Dec 2020 reached $9.1 million, up 28.34%, while the annual FY2025 figure was $20.9 million, 12.28% down from the prior year.
  • Operating Expenses for Q4 2020 was $4.2 million at enVVeno Medical, up from $1.9 million in the prior quarter.
  • Over five years, Operating Expenses peaked at $4.2 million in Q4 2020 and troughed at $1.3 million in Q2 2017.
  • A 4-year average of $1.9 million and a median of $1.7 million in 2017 define the central range for Operating Expenses.
  • Biggest five-year swings in Operating Expenses: skyrocketed 151.48% in 2018 and later plummeted 38.66% in 2019.
  • Year by year, Operating Expenses stood at $2.0 million in 2017, then fell by 24.73% to $1.5 million in 2018, then grew by 13.27% to $1.7 million in 2019, then skyrocketed by 143.16% to $4.2 million in 2020.
  • Business Quant data shows Operating Expenses for NVNO at $4.2 million in Q4 2020, $1.9 million in Q3 2020, and $1.5 million in Q2 2020.